Sotiris Vandoros
Lecturer
Brunel University
Uxbridge, UB8 3PH
United Kingdom
Biography
Qualifications
- PhD Health Economics, LSE, 2010
Personal Biography
Sotiris is a Lecturer in Economics at the Department of Economics & Finance at Brunel University. Prior to joining Brunel, he worked as a Research Fellow at the London School of Economics. He has conducted research for international organisations and governments such as WHO, the European Commission and the European Parliament. He has taught on MSc programmes at the LSE since 2008 as well as at other institutions, including Sorbonne-Cite and the Tata Institute of Social Sciences.Research
Research Overview
Sotiris’ research focuses on health economics, pharmaceutical economics and policy, industrial organisation and experimental economics. In particular, he has worked on pharmaceutical competition, pricing and reimbursement, tendering, parallel trade, access to medicines, therapeutic substitution, health and financial crisis, the economics of preventative healthcare, behavioural health economics and consumers’ preferences on currency denomination.External Activity
- Consultant to international organisations on pharmaceutical economics and policy
Publications
Publications
Journal Papers
(2013) Vandoros, S., Therapeutic substitution post-patent expiry: The cases of ACE inhibitors and proton pump inhibitors (forthcoming), Health Economics
(2013) Kanavos, P., Ferrario, A., Vandoros, S. and Anderson, GF., Higher US Branded Drug Prices And Spending Compared To Other Countries May Stem Partly From Quick Uptake Of New Drugs, Health Affairs 32 (4)
(2013) Vandoros, S., Hessel, P., Leone, T. and Avendano, M., Have health trends worsened in Greece as a result of the financial crisis? A quasi-experimental approach, European Journal of Public Health
(2013) Vandoros, S., My five pounds are not as good as yours, so I will spend them, Experimental Economics
(2013) Vandoros, S. and Kanavos, P., Parallel trade and pharmaceutical prices: A game-theoretic approach and empirical evidence from the European Union, The World Economy
(2013) Vandoros, S. and Kanavos, P., The generics paradox revisited: Empirical evidence from regulated markets, Applied Economics 45 (22) : 3230- 3239
(2013) Vandoros, S. and Stargardt, T., Reforms in the Greek pharmaceutical market during the financial crisis., Health Policy 109 (1) : 1- 6 Download publication
(2012) Naci, H., Cylus, J., Vandoros, S., Sato, A. and Perampaladas, K., Raising the bar for market authorisation of new drugs., BMJ 345 e4261- Download publication
(2012) Bradley, J. and Vandoros, S., Creative compliance in pharmaceutical markets: the case of profit controls., Expert Rev Pharmacoecon Outcomes Res 12 (1) : 31- 38 Download publication
(2011) von der Schulenburg, F., Vandoros, S. and Kanavos, P., The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors, Health Economics Review 1
(2011) Kanavos, P. and Vandoros, S., Drugs US: Are prices too high?: Measuring international pharmaceutical price differences, Significance 8 (1) : 15- 18
(2011) Bertoldi, AD., Barros, AJD., Camargo, AL., Hallal, PC., Vandoros, S., Wagner, A. and Ross-Degnan, D., Household expenditures for medicines and the role of free medicines in the brazilian public health system, American Journal of Public Health 101 (5) : 916- 921
(2011) Kanavos, PG. and Vandoros, S., Determinants of branded prescription medicine prices in OECD countries., Health Econ Policy Law 6 (3) : 337- 367 Download publication
(2010) Kanavos, P. and Vandoros, S., Competition in prescription drug markets: Is parallel trade the answer?, Managerial and Decision Economics 31 (5) : 325- 338
(2009) Kanavos, P., Vandoros, S. and Garcia-Gonzalez, P., Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP., Global Health 5 19- Download publication
